Nitrosooxypropanol

N/A

Report date: 2024/04/18 13:54:25
NME

Base Information

Drug NameNitrosooxypropanol
Drug Alias NamePDNOSupernitro
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGuanylate cyclase stimulantsNitric oxide donorsVirus replication inhibitors
TargetsGuanylate cyclase
Therapy Area/IndicationsArterial Occlusive DiseasesPulmonary EmbolismPulmonary Arterial Hypertension +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAttgeno AB
China Registration ClassN/A

Develop Information

Active CompaniesAttgeno AB
Inactive CompaniesN/A
Active IndicationsArterial Occlusive DiseasesPulmonary EmbolismPulmonary Arterial Hypertension +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A